Clinical Trial Update: Characterization of [11C]Flumazenil to Image GABA Transmission in Healthy Adult Subjects and Subjects With Alcohol Dependence [Phase 1]

View source ↗

Summary

A Phase 1 study characterizes the PET imaging agent [11C]Flumazenil for imaging GABA transmission in healthy adults and individuals with alcohol use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• [11C]Flumazenil (Flumazenil (carbon-11 labeled PET tracer))

Snippet

Sponsor: Rajesh Narendran | Conditions: Alcoholism | Phase 1 | Status: COMPLETED